SG11202112592YA - Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine - Google Patents
Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadineInfo
- Publication number
- SG11202112592YA SG11202112592YA SG11202112592YA SG11202112592YA SG11202112592YA SG 11202112592Y A SG11202112592Y A SG 11202112592YA SG 11202112592Y A SG11202112592Y A SG 11202112592YA SG 11202112592Y A SG11202112592Y A SG 11202112592YA SG 11202112592Y A SG11202112592Y A SG 11202112592YA
- Authority
- SG
- Singapore
- Prior art keywords
- olopatadine
- mometasone
- treatment
- combination
- allergic rhinitis
- Prior art date
Links
- 206010039085 Rhinitis allergic Diseases 0.000 title 1
- 201000010105 allergic rhinitis Diseases 0.000 title 1
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 title 1
- 229960001664 mometasone Drugs 0.000 title 1
- JBIMVDZLSHOPLA-LSCVHKIXSA-N olopatadine Chemical compound C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 JBIMVDZLSHOPLA-LSCVHKIXSA-N 0.000 title 1
- 229960004114 olopatadine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/903,597 US10758550B2 (en) | 2013-10-04 | 2018-02-23 | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| PCT/IB2019/051465 WO2019162902A1 (en) | 2018-02-23 | 2019-02-22 | Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202112592YA true SG11202112592YA (en) | 2021-12-30 |
Family
ID=65818565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202112592YA SG11202112592YA (en) | 2018-02-23 | 2019-02-22 | Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP3755375B1 (en) |
| JP (1) | JP7391026B2 (en) |
| KR (1) | KR102709429B1 (en) |
| CN (1) | CN111787954B (en) |
| AU (1) | AU2019224850B2 (en) |
| BR (1) | BR112020016817A2 (en) |
| CA (1) | CA3088490A1 (en) |
| CO (1) | CO2020010335A2 (en) |
| EA (1) | EA202091744A1 (en) |
| ES (1) | ES3017701T3 (en) |
| HR (1) | HRP20250411T1 (en) |
| HU (1) | HUE071622T2 (en) |
| MX (1) | MX2020008741A (en) |
| MY (1) | MY208695A (en) |
| PH (1) | PH12020551311A1 (en) |
| PL (1) | PL3755375T3 (en) |
| SG (1) | SG11202112592YA (en) |
| WO (1) | WO2019162902A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250161328A1 (en) * | 2023-11-21 | 2025-05-22 | Glenmark Specialty S.A. | Nasal spray composition |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8520662D0 (en) | 1985-08-17 | 1985-09-25 | Wellcome Found | Tricyclic aromatic compounds |
| US4923892A (en) | 1985-08-17 | 1990-05-08 | Burroughs Wellcome Co. | Tricyclic aromatic compounds |
| US6127353A (en) | 1991-09-06 | 2000-10-03 | Schering Corporation | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| PE44995A1 (en) | 1994-01-27 | 1995-12-18 | Schering Corp | MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT |
| AU7859800A (en) * | 1999-10-08 | 2001-04-23 | Schering Corporation | Topical nasal treatment |
| US7977376B2 (en) | 2001-06-27 | 2011-07-12 | Novartis Ag | Olopatadine formulations for topical nasal administration |
| JP2006508138A (en) * | 2002-11-12 | 2006-03-09 | アルコン，インコーポレイテッド | Use of antiallergic agents and steroids to treat allergic rhinitis |
| US20070099883A1 (en) * | 2005-10-07 | 2007-05-03 | Cheryl Lynn Calis | Anhydrous mometasone furoate formulation |
| PT2173169E (en) * | 2007-06-28 | 2014-09-03 | Cydex Pharmaceuticals Inc | Nasal delivery of aqueous corticosteroid solutions |
| WO2010025236A1 (en) | 2008-08-27 | 2010-03-04 | Alexander Goldin | Composition and method for treating colds |
| PT2453872E (en) | 2009-07-17 | 2013-10-30 | Alcon Res Ltd | Olopatadine nasal spray regimen for children |
| CN102078326A (en) * | 2009-11-26 | 2011-06-01 | 天津金耀集团有限公司 | Topically applied composition containing povidone iodine and mometasone furoate |
| CN102078285A (en) * | 2009-11-26 | 2011-06-01 | 天津金耀集团有限公司 | Nasal in-situ gel containing corticosteroids and H1 receptor antagonists |
| WO2011141929A2 (en) | 2010-05-11 | 2011-11-17 | Cadila Healthcare Limited | Aqueous pharmaceutical compositions of fluticasone and olopatadine |
| EP2736491B1 (en) * | 2011-01-04 | 2017-04-05 | Bausch & Lomb Incorporated | Bepotastine compositions |
| US9370483B2 (en) * | 2013-09-13 | 2016-06-21 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| US10646500B2 (en) * | 2013-10-04 | 2020-05-12 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
-
2019
- 2019-02-22 BR BR112020016817-3A patent/BR112020016817A2/en unknown
- 2019-02-22 PL PL19712287.2T patent/PL3755375T3/en unknown
- 2019-02-22 MX MX2020008741A patent/MX2020008741A/en unknown
- 2019-02-22 CN CN201980014453.0A patent/CN111787954B/en active Active
- 2019-02-22 EP EP19712287.2A patent/EP3755375B1/en active Active
- 2019-02-22 EA EA202091744A patent/EA202091744A1/en unknown
- 2019-02-22 ES ES19712287T patent/ES3017701T3/en active Active
- 2019-02-22 HR HRP20250411TT patent/HRP20250411T1/en unknown
- 2019-02-22 KR KR1020207025829A patent/KR102709429B1/en active Active
- 2019-02-22 CA CA3088490A patent/CA3088490A1/en not_active Abandoned
- 2019-02-22 WO PCT/IB2019/051465 patent/WO2019162902A1/en not_active Ceased
- 2019-02-22 SG SG11202112592YA patent/SG11202112592YA/en unknown
- 2019-02-22 AU AU2019224850A patent/AU2019224850B2/en active Active
- 2019-02-22 HU HUE19712287A patent/HUE071622T2/en unknown
- 2019-02-22 JP JP2020544007A patent/JP7391026B2/en active Active
- 2019-02-22 MY MYPI2020004258A patent/MY208695A/en unknown
-
2020
- 2020-08-21 CO CONC2020/0010335A patent/CO2020010335A2/en unknown
- 2020-08-22 PH PH12020551311A patent/PH12020551311A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ766523A (en) | 2025-07-25 |
| KR102709429B1 (en) | 2024-09-24 |
| AU2019224850A1 (en) | 2020-08-13 |
| CN111787954B (en) | 2023-09-05 |
| RU2020126691A3 (en) | 2022-03-23 |
| KR20200125625A (en) | 2020-11-04 |
| AU2019224850B2 (en) | 2024-11-28 |
| ES3017701T3 (en) | 2025-05-13 |
| PL3755375T3 (en) | 2025-06-09 |
| BR112020016817A2 (en) | 2020-12-15 |
| HRP20250411T1 (en) | 2025-07-18 |
| CO2020010335A2 (en) | 2020-11-10 |
| EA202091744A1 (en) | 2021-01-15 |
| WO2019162902A1 (en) | 2019-08-29 |
| PH12020551311A1 (en) | 2021-09-06 |
| RU2020126691A (en) | 2022-03-23 |
| EP3755375A1 (en) | 2020-12-30 |
| JP2021514947A (en) | 2021-06-17 |
| CA3088490A1 (en) | 2019-08-29 |
| EP3755375C0 (en) | 2025-03-05 |
| MY208695A (en) | 2025-05-25 |
| EP3755375B1 (en) | 2025-03-05 |
| JP7391026B2 (en) | 2023-12-04 |
| HUE071622T2 (en) | 2025-09-28 |
| MX2020008741A (en) | 2020-09-28 |
| CN111787954A (en) | 2020-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL281445A (en) | Therapeutic nanoparticles and methods of use thereof | |
| IL263985A (en) | Medical device for treatment of a sinus and/or an ear and methods of use thereof | |
| IL276494A (en) | Pediatric niraparib formulations and pediatric treatment methods | |
| IL281898A (en) | Scaffolding for implantable medical devices and methods of use thereof | |
| IL254791A0 (en) | Artery medical apparatus and methods of use thereof | |
| IL264301A (en) | Treatment of fabry disease in ert-naive and ert-experienced patients | |
| ZA201504740B (en) | Treatment of allergic rhinitis using a combination of mometasone and olopatadine | |
| SG11202113307TA (en) | Cot modulators and methods of use thereof | |
| EP3831356C0 (en) | MASSAGE ARRANGEMENT AND MASSAGE DEVICE FOR HUMAN BODY | |
| GB2604264B (en) | Medical treatment device and method of operation thereof | |
| PT3498177T (en) | Tissue closing device and medical instrument | |
| IL269507A (en) | Medical devices comprising detachable balloons and methods of manufacturing and use | |
| SG11202000423XA (en) | Treatment of fabry disease in ert-naïve and ert-experienced patients | |
| EP3796877A4 (en) | STIMULATION AND TREATMENT DEVICE | |
| EP3872740A4 (en) | ASSISTANCE DEVICE AND ASSISTANCE PROCEDURES | |
| EP3852650A4 (en) | Tissue care device and method of use | |
| SG11202112592YA (en) | Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine | |
| EP4486420A4 (en) | PATIENT INTERFACE AND BREATHING DEVICE | |
| SG11202101184VA (en) | Device for massaging and stretching certain body parts | |
| SG11202005186QA (en) | Device for treatment of a body canal and adjacent surfaces | |
| GB2574747B (en) | Use of lambda interferons in the treatment of obesity-related disorders and related diseases | |
| IL280859A (en) | Use of gaboxadol in the treatment of gastrointestinal tract disorders and asthma | |
| PL3628356T3 (en) | Medical instrument and creation device | |
| IL284689A (en) | Endoscopic device and methods of use thereof | |
| EP4221794A4 (en) | PATIENT INTERFACE AND COMPONENTS THEREOF |